Effects of specialised and centralised versus generalised and decentralised outpatient treatment for progressed bipolar disorder: Results from the CAG Bipolar randomised controlled trial
In brief
Specialized bipolar care did not reduce hospitalizations, but patients were more satisfied
In a randomized trial of 1,134 people with progressed bipolar disorder, specialized centralized care did not reduce psychiatric hospitalizations over 12 months or improve symptoms, quality of life, or coercion outcomes. It led to more lithium and antipsychotic prescribing and greater satisfaction with care, but whether those differences translate into better long-term outcomes remains unknown.
- Journal
- Psychological medicine (Q1)
- Published
- 20 November 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Lars Vedel Kessing, Natacha Blauenfeldt Kyster, Ellen Margrethe Christensen, Sarah Krarup Larsen, Birte Smidt, Ulla Knorr, et al.
- PMID
- 43059297
- DOI
- 10.1017/S0033291726106606
Why clinicians should know about it
- Picked for Psychiatry and Mental Health (top studies of the week, 22 November 2026): Large randomized trial compares specialist bipolar outpatient services
Abstract
BACKGROUND: Clinical Academic Group (CAG) is a new organization of treatment bringing together clinical services, research, education, and training to provide evidence-based care. We aimed, for the first time, to investigate whether specialized and centralized outpatient treatment (CAG Bipolar) versus decentralized community-based treatment improves patient outcomes and satisfaction with care in patients with progressed bipolar disorder. METHODS: A pragmatic randomized controlled trial was undertaken with individual randomization to 1) specialized and centralized outpatient treatment in CAG Bipolar or 2) generalized and decentralized community-based outpatient treatment. The 12-month outcomes were 1) cumulated number and duration of psychiatric hospitalizations, and 2) psychotropic medication, coercion, self-rated depressive and manic symptoms, quality of life, perceived stress, and satisfaction with care. RESULTS: There was no difference among 1,134 included patients in cumulated number (RR: 0.94 (95% CI: 0.74-1.14), p = 0.6) or duration (0.16 days, (95% CI: -4.10-4.42; p = 0.9) of psychiatric hospitalizations. Lithium (RR: 1.19 (95% CI: 1.05-1.33) and antipsychotics (RR: 1.09 (95% CI: 1.01-1.17), specifically quetiapine (RR: 1.17 (95% CI: 1.03-1.30), were prescribed more in the CAG Bipolar group, and CAG Bipolar patients were overall more satisfied with care including the skills of the professionals, information and the efficacy of the service. There was no difference in coercion, self-rated depressive or manic symptoms, quality of life or perceived stress. CONCLUSIONS: Specialized and centralized outpatient treatment for progressed bipolar disorder does not result in improvement in robust outcome measures such as hospitalization and coercion, but in the use of psychotropic medication concordant with international guidelines, and increased satisfaction with care.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.